Author:
Martin-Padura Ines,Marighetti Paola,Agliano Alice,Colombo Federico,Larzabal Leyre,Redrado Miriam,Bleau Anne-Marie,Prior Celia,Bertolini Francesco,Calvo Alfonso
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,Pathology and Forensic Medicine
Reference45 articles.
1. Llovet JM, Burroughs A, Bruix J . Hepatocellular carcinoma. Lancet 2003;362:1907–1917.
2. Voiculescu M, Winkler RE, Moscovici M, et al. Chemotherapies and targeted therapies in advanced hepatocellular carcinoma: from laboratory to clinic. J Gastrointestin Liver Dis 2008;17:315–322.
3. Hoshida Y, Villanueva A, Kobayashi M, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008;359:1995–2004.
4. Hanahan D, Bergers G, Bergsland E . Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest 2000;105:1045–1047.
5. Bertolini F, Paul S, Mancuso P, et al. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 2003;63:4342–4346.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献